News

In the ninth episode, Nicholas and Lana unpack several longevity launches making waves, and why regulatory clearance, novelty, and clinical data are 3 separate things brands shouldn't blur together.

Part 2 of our interview with Todd Harrison, co-chair of the FDA practice group at Venable LLP covers preclusion's structural gaps: no defined end point, no tracking registry, and a push for mandatory drug-sponsor engagement.

Todd Harrison, co-chair of the FDA practice group at Venable LLP, details the Dietary Supplement Innovation Act's language, its unintended consequences, and what industry stakeholders should watch for.

The company's newest chewable concepts pair postbiotics with biotin and vitamin D3 to support skin, hair, and immune health.

The company's "IVC Advantage" pairs market research with formulation and manufacturing scale for brands launching products.

A randomized, crossover trial found that ThymoDream, a standardized black cumin seed oil, raised endogenous melatonin levels and improved several sleep measures over 7 nights, with lower reported daytime sleepiness than synthetic melatonin.

Ahead of the Las Vegas trade show, BSCG outlines how its five certification programs address banned substances, label accuracy, GMP compliance, and CBD verification.

Research conducted on beauty and nutritional needs for women in Asia-Pacific outlines needs across four life stages and what they mean for supplement formulators.

Piping Rock Health Products has launched a 300-mg NMN gummy under its Vitafusion brand, arriving less than a year after the FDA reversed its position on whether the ingredient could legally be sold as a dietary supplement.

The precision-granule platform Tailored Script enters the U.S. and Australian markets, giving brands and practitioners a way to manufacture individualized formulations at scale.

The Indian branded-ingredient supplier has closed a growth investment from NDude Labs to expand clinical research and establish a dedicated US commercial operation, reflecting investor interest in ingredient companies that lead with published data.

The company introduces Gut & Protein Optimizer, a probiotic-enzyme formula for protein utilization, and NMN 300 mg, an NAD+ precursor.

Built on Calanus Oil and ORIVO-verified fish oil, the concept targets brands seeking faster, differentiated omega-3 product development.

A mixed cell-culture and mouse study found that Ahiflower oil, a plant-based omega-3 source, reduced markers of endothelial inflammation, blood lipids, and platelet clotting activity at levels comparable to fish oil.

Nova Mentis's HT1 ingredient bypasses olive extraction, aiming to give formulators a more consistent supply of the polyphenol.

The appointment comes as the CDMO continues to expand its gummy, softgel, and fizzy tablet format offerings for brand partners.

At the Future Nutra Innovation Summit, PLT Health's Steve Fink discusses joint, cognitive, and longevity nutrition explaining why "experiential longevity" is reshaping formulation strategy.

Pooled RCT evidence from three EU consortia shows non-nutritive sweeteners may support weight loss maintenance without adverse effects on biomarkers or taste preference.

CHAKHAN Co. has launched a black seed oil supplement in South Korea built on TriNutra's ThymoQuin ingredient, extending the branded ingredient's international footprint into a market where it has not previously been sold under a local retail brand.

CoreFX Ingredients is opening a European headquarters and research operation in County Cork, Ireland, partnering with a public agricultural research campus to work on formulation problems that have long limited how bioactive compounds perform in finished nutraceutical products.

Live from the Future Nutra Innovation Summit, Kerry Hughes, founder and president of Ethnopharm, explains why botanicals' complex compound networks represent nutrition's next innovation frontier.

A year-to-date look at the various forces pushing digestive health formulation toward more precise, mechanism-driven claims.

Nammex is bringing its already-introduced ErinaPrime Lion's mane mycelium ingredient, standardized to a specific neuroactive compound, to SupplySide Global.

A laboratory study using human liver cells found that Optifolin+, a choline-enriched form of 5-methyltetrahydrofolate, increased methyl-donor metabolite levels, adding cell-based data to the folate ingredient's evidence base ahead of any human methylation research.

The >Your< Hydramin+ Sticks target the growing overlap between functional hydration, sports nutrition, and beauty-from-within supplements.

The Dietary Supplement Innovation Act, introduced by Rep. Harshbarger, would cap indefinite preclusion, require science-based review standards, and open FDA warnings to court challenge.

Paul Eftang used his FNIS session to walk through lab data on lion's mane and Tongkat Ali products that pass identity and DNA testing while containing few or none of the bioactive compounds their marketing claims are based on.

At the Future Nutra Innovation Summit, Sibyl Swift, PhD, founder and principal of Swift Strategy Group, discusses supplement oversight and unpacks why mandatory product listing divides the industry.